Journal of Gynecologic Oncology

Abbr. J GYNECOL ONCOL ·SOUTH KOREA ·Frequency Quarterly ·Avg. articles/yr 36 articles

3.7

Latest IF

3.70%

Self-citation

较易

Submission difficulty

>12周，或约稿

Review cycle

About Journal

Journal of Gynecologic Oncology是一本专注于妇科肿瘤学研究的国际期刊，ISSN号为2005-0380，由韩国妇科肿瘤学会（Korean Society of Gynecologic Oncology）出版，出版地为韩国，出版周期为季刊。该期刊是开放获取（OA）期刊，被SCI收录，2022年影响因子为3.9，在中科院分区中属于医学大类3区。杂志的发文特点是以妇科肿瘤的临床与基础研究为主，涵盖宫颈癌、卵巢癌、子宫内膜癌等疾病的诊断、治疗及分子机制研究，尤其注重亚洲人群的相关数据。其质量较高，审稿流程严格，但作为OA期刊可能存在一定的出版费用风险，且影响因子波动较小，学术声誉稳定，适合妇科肿瘤领域的研究者投稿。

IF Trend

Recent Articles

Current status of fertility preservation for borderline ovarian tumor in Asian countries: results from ASGO-special task force for fertility preservation; part II. Fertility and pregnancy planning following initial treatment 2026-09-15

Correlation of bevacizumab relative dose intensity with first-line treatment outcomes in advanced epithelial ovarian cancer 2026-09-16

Changes in the extensiveness of initial debulking surgery with increasing neoadjuvant chemotherapy use in advanced ovarian cancer: a nationwide population-based study 2026-07-22

Survey on the current status of novel cancer drug therapies for gynecological cancers in Japan: a nationwide survey by the Japan Society of Obstetrics and Gynecology (JSOG) 2026-09-14

Current status of fertility preservation for borderline ovarian tumor in Asian regions: results from ASGO-special task force for fertility preservation; part I. Fertility-sparing treatment for borderline ovarian tumor 2026-09-15

Clinical effectiveness of laparoscopic versus open surgery for apparently early-stage endometrial cancer: Application of a treatment effect model 2026-07-15

A confirmatory trial of hysterectomy with minimal parametrectomy for stage IB1 cervical cancer involving a tumor diameter of 2 cm or less: a Japan Clinical Oncology Group study (JCOG1101) 2026-07-22

Prognosis and risk factors by histologic type of malignant ovarian germ cell tumors in Japan: a JSOG gynecologic tumor registry-based study 2026-09-14

Outcome of advanced ovarian cancer patients who do not undergo cytoreductive surgery in the era of PARP inhibitors maintenance therapy: a propensity score-based analysis 2026-07-22

The real-world practice of fertility preservation for patients with epithelial ovarian cancer in Asian regions 2026-08-27